Yes. The United States Food & Drug Administration has cleared Xtrallux hair regrowth devices as effective for treating androgenetic alopecia (see full indication for use). The clearance is based on substantiation by earlier submissions to the FDA providing clinical data to verify that this type of medical device emitting red laser energy results in an increase in terminal hair counts over the course of time with continued use. Terminal hair is defined as long, coarse, well-pigmented hair which differs from vellus hair.
Xtrallux manufactures devices use this technology which has been proven to increase counts of terminal hair in clinical trials accepted as substantiation by the FDA for prior clearances for this device classification.
Keep in mind that results will vary from person to person. Each case is different.